https://www.selleckchem.com/pr....oducts/pf-3758309.ht
In the future, risk-adapted treatment concepts will include decision making for chemotherapy but also for endocrine-based approaches. Determination of recurrence risk will remain important in luminal EBC for optimal therapy decisions. In the future, risk-adapted treatment concepts will include decision making for chemotherapy but also for endocrine-based approaches. This review demonstrates the evidence for new systemic anticancer treatments and how they integrate within conventional management for gestational trophoblastic neoplasia
Like
Comment
Share
